Disposition and pharmacokinetics of a GalNAc3-Conjugated antisense oligonucleotide targeting human lipoprotein (a) in monkeys

被引：0
|
作者：
不详
机构：
来源：
CHIMICA OGGI-CHEMISTRY TODAY | 2018年 / 36卷 / 02期
关键词：
Oligonucleotide; phosphorothioate; oligonucleotide conjugate; antisense; GalNAc; lipoprotein; pharmacokinetics; ISIS; 681257;
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [41] Lack of pharmacokinetic interactions of an antisense oligonucleotide, targeting human apoB, when coadministered with simvastatin & ezetimibe, in man
    Geary, R.
    Yu, R.
    Bradley, J.
    Chuang, E.
    Wedel, M.
    Vanvliet, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 549 - 549
  • [42] Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple ascending doses of AZD2373, an antisense oligonucleotide targeting APOL1
    Greasley, Peter J.
    Agrawal, Nikhil
    Althage, Magnus
    Sanchez, Jose
    Kirk, Sarah
    Egeland, Erlend Johannessen
    Astrand, Magnus
    Westergren, Helena
    Sherwood, James
    Mccarthy, Michael
    Patel, Uptal
    Macphee, Iain
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1134 - I1135
  • [43] Pharmacokinetics of recombinant human interleukin-3 in rhesus monkeys
    汤仲明
    刘秀文
    屠敏
    Science in China(Series C:Life Sciences), 1997, (05) : 546 - 553
  • [44] Pharmacokinetics of recombinant human interleukin-3 in rhesus monkeys
    Zhongming Tang
    Xiuwen Liu
    Min Tu
    Science in China Series C: Life Sciences, 1997, 40 : 546 - 553
  • [45] Pharmacokinetics of recombinant human interleukin-3 in rhesus monkeys
    Tang, ZM
    Liu, XW
    Tu, M
    SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 1997, 40 (05): : 546 - 553
  • [46] Targeting TGF-ss in the Central Nervous System: Assessment of Cynomolgus Monkey-Toxicity and Pharmacokinetics for an LNA-Antisense Oligonucleotide
    Peters, Sebastian
    Wirkert, Eva
    Kuespert, Sabrina
    Heydn, Rosmarie
    Korte, Sven
    Mecklenburg, Lars
    Aigner, Ludwig
    Johannesen, Siw
    Bruun, Tim-Henrik
    Bogdahn, Ulrich
    APPLIED SCIENCES-BASEL, 2022, 12 (03):
  • [47] Antisense oligonucleotide targeting survivin inhibits growth by inducing apoptosis in human osteosarcoma cells MG-63
    Wu, Y. F.
    Liang, X. J.
    Liu, Y. Y.
    Gong, W.
    Liu, J. X.
    Wang, X. P.
    Zhuang, Z. Q.
    Guo, Y.
    Shen, H. Y.
    NEOPLASMA, 2010, 57 (06) : 501 - 506
  • [48] Tissue disposition and pharmacokinetics of recombinant human nerve growth factor after acute and chronic subcutaneous administration in monkeys
    Nguyen, CB
    Harris, L
    Szönyi, E
    Baughman, SA
    Hale, VG
    Dybdal, NO
    Sadick, MD
    Escandón, E
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (05) : 598 - 607
  • [49] First human dose study evaluating safety and pharmacokinetics of LY2181308, an antisense oligonucleotide designed to inhibit survivin
    Talbot, D. C.
    Davies, J.
    Callies, S.
    Andre, V.
    Lahn, M.
    Ang, J.
    De Bono, J. S.
    Ranson, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [50] Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice
    Merki, Esther
    Graham, Mark J.
    Mullick, Adam E.
    Miller, Elizabeth R.
    Crooke, Rosanne M.
    Pitas, Robert E.
    Witztum, Joseph L.
    Tsimikas, Sotirios
    CIRCULATION, 2008, 118 (07) : 743 - 753
12345